General Information of Drug (ID: DMO5EBI)

Drug Name
3-dodecyl-1,1-dimethylthiourea Drug Info
Synonyms CHEMBL251521; 3-dodecyl-1,1-dimethylthiourea
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
44442157
TTD Drug ID
DMO5EBI

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Acetohydroxamic Acid DMYX7NI Urinary tract infection GC08 Approved [2]
3-(4-bromobenzyl)-1,1-dimethylselenourea DMAKMIJ Discovery agent N.A. Investigative [1]
1-cyclohexyl-1-isopropyl-3,3-dimethylselenourea DMS10LE Discovery agent N.A. Investigative [1]
N-glycylglycinehydroxamic acid DMPEZHC Discovery agent N.A. Investigative [3]
3-(4-bromophenyl)-1,1-dimethylthiourea DMXMZRE Discovery agent N.A. Investigative [1]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Bacterial Urease (Bact ureC) TTAS2UO URE1_KLEAE Inhibitor [1]

References

1 Facile one-pot synthesis of thio and selenourea derivatives: a new class of potent urease inhibitors. Bioorg Med Chem Lett. 2007 Nov 15;17(22):6387-91.
2 Enzymatic, immunological and phylogenetic characterization of Brucella suis urease. BMC Microbiol. 2008 Jul 19;8:121.
3 Design, synthesis, and evaluation of novel organophosphorus inhibitors of bacterial ureases. J Med Chem. 2008 Sep 25;51(18):5736-44.